chrisvoncsefalvay/vaers-outcomes huggingface dataset:
more than 36 days since received the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (more than 36 days since received the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (more than 36 days since received the first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (more than 36 days since received the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided by the reporter  No treatment medication were provided by the reporter
NO ADVERSE EVENT REPORTED. PATIENT WAS 17 YEARS OLD AT TIME OF 1ST VACCINE. PATIENT RECEIVED DOSE AS PART OF A LARGE, MULTI-LANGUAGE VACCINE CLINIC. AFTER THE VACCINE WAS ADMINISTERED AND PATIENT LEFT, HER REPORTED AGE WAS NOTED AND THE QUESTION AROSE OF CORRECTNESS OF THE REPORT.  ATTEMPTS WERE MADE TO CONTACT THE PATIENT TO CONFIRM HER DOB WITHOUT RESOLUTION. A NOTE WAS LEFT WITH HER CONSENT FORM FOR HER SCHEDULED SECOND DOSE. DUE TO MISCOMMUNICATION, I DID NOT SPEAK WITH HER PRIOR TO HER RECEIVING HER SECOND DOSE.
Appointment time was 3:45pm, received the booster shot at about 4:15pm.  Waited in the store for 45 minutes after the shot - anaphylactic reaction to peanuts, tree nuts, legumes, natural soy, etc., so was asked to wait at least  30 mins - was also waiting on a friend who was also getting booster, so did not leave pharmacy until about 5:00pm.  Dropped friend off at her place close by and headed home.   While on the drive home, my jawline began to lock up, both sides of my neck began to stiffen, my upper lip started swelling (was about 5:10pm at this time).  Recognizing the signs of severe allergic reaction, I took two (a total of 25 mgs) of children's chewable Benadryl (I carry it at all times along with my Epipens per doctor's advice).  Symptoms were not relieved by the time I arrived home at 5:15pm, so took an adult Benadryl (another 25 mg) and called my neighbor to come over in case I needed to call 911.  She stated my face was very red and swollen.   Symptoms began to relieve at about 5:30pm; neighbor stayed with me for another hour.  Almost all symptoms were gone by 7:00pm;  the only thing that remained was tightness in the joints of my jaw on both sides.  That finally dissipated by 10:00pm.  Since symptoms began to dissipate after taking the Benadryl, I did not have to call 911 and elected not to go to hospital given that they are very full right now.
Fever, chills, tachycardia, muscle aches, vomiting, diarrhea. Lasted 24hours, then resolved.
This spontaneous report as received from a nurse refers to unspecified patients of unknown age. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. On an unknown date the patient was vaccinated with improperly stored VAQTA (dosing details were not reported) (lot # M009377, expiry date: 17-JUN-2017) (lot # M018644, expiry date: 20-SEP-2017) and (lot # M022924, expiry date: 24-JAN-2018) for prophylaxis, which was stored at a temperature of 35 degree Fahrenheit for a time frame of 24.91 hours (incorrect product storage). No adverse effects were reported. No previous temperature excursions reported. The call was because of a data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1708USA002354.
This spontaneous report was received from a pharmacist refers to two patients of unknown demographics. On 23-OCT-2014, two patients were vaccinated with ZOSTAVAX, subcutaneous as prophylactic vaccination. The reporter stated that patient received ZOSTAVAX that was improperly exposed to 29F for 19 hours 40 minutes. No known adverse effects was reported. No product quality complaint was involved. This is one of the several reports from the same reporter source. Additional information has been requested.
p/vax herpes zoster rash w/numerous lesions on lower back;also had numerous clusters of vesicles w/erythema in between;pt given DPH & hydrocortisone;seen by MD who noticed pt had classic dermatomal distribution;
Patient received a vaccine that was diluted with 0.8ml of Nacl instead of 1.8ml of Nacl
Hot; Vomiting; Tired; headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hot), VOMITING (Vomiting), FATIGUE (Tired) and HEADACHE (headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032m20a) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced FEELING HOT (Hot), VOMITING (Vomiting), FATIGUE (Tired) and HEADACHE (headache). At the time of the report, FEELING HOT (Hot), VOMITING (Vomiting), FATIGUE (Tired) and HEADACHE (headache) outcome was unknown.            No concomitant medications were provided by the reporter.   Treatment information was not provided.
Right after she received the vaccination she felt dizzy and very thirsty. Her tongue was also numb for 3 days.
This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Arm still hurt this long after the shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Arm still hurt this long after the shot). At the time of the report, MYALGIA (Arm still hurt this long after the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided  Treatment medication was not provided
20 min past first ever flu vaccination, pt. experienced light headiness, pale, racing heart, tickly throat, gave pt, 10ml BENADRYL elixir, laid elevated, feet up , ice pack to neck, did not feel better, throat felt obstructed called 911, transported to ER, discharged home.
1 cm bump with redness at puncture sight, no pain, no itching. Probable minor reaction to vaccine.
This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 51-year-old female patient who received BOOSTRIX (batch number X9YP3, expiry date 2nd October 2020) for prophylaxis. On 12th September 2018, the patient received BOOSTRIX (intradermal). On 12th September 2018, several hours after receiving BOOSTRIX, the patient experienced injection site pain, injection site swelling, injection site wheal, wrong vaccine administered and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site pain, injection site swelling and injection site wheal were not recovered/not resolved and the outcome of the wrong vaccine administered and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the injection site pain, injection site swelling and injection site wheal to be related to BOOSTRIX. Additional details were provided as follows: The health care professional reported patient was administered a dose of BOOSTRIX Intradermally, which led to inappropriate route of vaccination. The patient was supposed to receive the TB test instead of BOOSTRIX, which led to wrong vaccine administered. The patient developed a welt on the forearm that was swollen and hurting several hours later on that same day. The health care professional recommended the patient apply ice to the affected area.
pt recvd vax; 9aug95 exp induration, swelling & erythema at inject site;
Changes to my vision occurred; I started to notice I was having trouble reading again; Blurrines was again very severe; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 21Apr2021 08:30 (Lot number: ER8735) at the age of 22 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "ADHD" (unspecified if ongoing); "PTSD" (unspecified if ongoing); "GAD" (unspecified if ongoing); "depression" (unspecified if ongoing); "borderline personality disorder" (unspecified if ongoing); "alcohol abuse disorder" (unspecified if ongoing); "mangoes" (unspecified if ongoing); "known allergies: Sulfa drugs" (unspecified if ongoing). Concomitant medication(s) included: MIRENA; VYVANSE; SPIRONOLACTONE.   Vaccination history included: Bnt162b2 (product: COVID 19 , brand: Pfizer, lot number: EW0150, lot unknown: False, administration date: 31Mar2021, administration time: 08:30 AM, dose number: 1, vaccine location: Left arm), administration date: 31Mar2021, when the patient was 22 years old, for covid 19 immunization, reaction(s): "The first shot was administered Mar 31st, on Apr 9th around midday I experience a sudden change in my close-up vision, everything suddenly appeared blurry (my distance vision was normal).". The following information was reported: VISUAL IMPAIRMENT (non-serious) with onset 2021, outcome "recovered", described as "Changes to my vision occurred"; VISUAL IMPAIRMENT (non-serious) with onset 2021, outcome "recovered", described as "I started to notice I was having trouble reading again"; VISION BLURRED (non-serious) with onset 2021, outcome "recovered", described as "Blurrines was again very severe". The events "changes to my vision occurred" and "i started to notice i was having trouble reading again" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of visual impairment, visual impairment, vision blurred.  No follow-up attempts are possible. No further information is expected
Seen in office for rash 10-4-13. Dx - Varicella. Had been sully immunized for varicella. VARIVAX vaccines 9-4-09, 11-27-12.
Swollen extending through the whole Rt arm upper arm, lower arm to 2 cm above wrist red sl swollen.
Developed COVID infection with day 0 of infection 10/18/2022. Symptoms initially included sore throat, and later included fever, chills, abdominal pain, headache, ocular pain, fatigue.
Some blood clot on both of her legs; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced some blood clot on both of her legs on an unspecified date. It was reported that patient would have a procedure on Friday and then she was going to go for the vaccination on Saturday. they would like to known if there was any problem for her to have the vaccination done. The outcome of the event was unknown.  No follow-up attempts are possible; information about batch number cannot be obtained.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient had an unspecified reaction to a "TB test or PPD" at an unspecified time in the past. On 19-JUL-2014 the patient was vaccinated with PNEUMOVAX23 in the left arm (dose, and route were not reported; lot number K004281, expiration date 22-FEB-2015). Concomitant therapies included hydrochlorothiazide (manufacturer unknown); simvastatin (manufacturer unknown), lisinopril (manufacturer unknown) XANAX, ibuprofen, mirtazepine (manufacturer unknown), metoprolol, ATROVENT and amlodipine. On an unspecified date in July 2014 the patient developed redness and swelling of her left arm at the injection site after receiving PNEUMOVAX23 and the events was not reported. The patient had an office visit with an unspecified physician. Additional information has been requested.
16 days after receiving Varicella vaccine child developed varicella rash- child has had intermittal lesions since receiving vaccine.
This case was reported by a physician via call center representative and described the occurrence of vertigo in male patient who received SHINGRIX. Concomitant products included lamotrigine. In April 2018, the patient received SHINGRIX. In April 2018, less than a month after receiving SHINGRIX, the patient experienced vertigo. On an unknown date, the outcome of the vertigo was unchanged. It was unknown if the reporter considered the vertigo to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. About 4 to 5 weeks before the date of reporting, the patient received SHINGRIX. The patient experienced 3 episodes of vertigo since the vaccination.
Eyes were burning; eyelids swollen; my heart rate went from resting to 116; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Eyes were burning), SWELLING OF EYELID (eyelids swollen) and HEART RATE ABNORMAL (my heart rate went from resting to 116) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic shock (Due to penicillin allergy).    On 05-Mar-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced EYE IRRITATION (Eyes were burning), SWELLING OF EYELID (eyelids swollen) and HEART RATE ABNORMAL (my heart rate went from resting to 116). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, EYE IRRITATION (Eyes were burning), SWELLING OF EYELID (eyelids swollen) and HEART RATE ABNORMAL (my heart rate went from resting to 116) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: unknown (High) 116.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was given Benadryl and was observed for 30 minutes. List of concomitant medication were not given.
Noticed pain in upper left arm upon lifting arm upwards, soreness, range of motion limited.
Symptoms began about 4 hr after injection. Not feeling well, then chills/fever, then joints aching and swollen lymph in armpit. Used tylenol/ibuprofen. Arm swollen at injection site. Asthma exacerbated.
Patient stated that this shot (6 August 2021) was his second dose in his Pfizer series. It was not caught until the shot was being documented that it was seen that the patient had his two shot series in January 2021. The patient waited the 30 minute wait and no symptoms were noted.
Redness, swelling at MMR site SQ approx 6cm in diameter (L) almost immediately after immunization.
Patient's wife reported that patient died a couple of days after second Moderna vaccine. About 2 days after vaccine, patient presented with lumps all around body and doctor's could not figure out what was wrong. His digestive tract started to deteriorate and he passed away at home. Autopsy was performed but could not confirm cause of death.
After receiving vaccination, right arm was swollen and felt cold to the touch, kept arm elevated to try to keep the swelling down and took hydroxine at night to try to help it go down. Still could feel my radio pulse, felt like pins and needles. Not cold anymore, now feels warm/burning sensation.
COVID-19 Vaccine EUA. I am having knee joint pain, in the R knee. Have never experienced this before. I knew it was a potential side effect so I'm not panicking, but felt it was important to report. I can walk fine but it hurts when I move it. Unrelieved by massage. I've been taking Advil for the pain. If it continues I will contact my Primary Care Physician. I am an RN.
Limp, pale, hypo responsive the evening vaccines were given. Taken via ambulance to hospital
No adverse effects reported; patient received dose of PNEUMOVAX 23 that was improperly stored; This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 10-OCT-2019, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # S012246, expiration date 10-FEB-2021 (dose and route of administration were not reported). There were no adverse effects reported. Administered dose of vaccine experienced the temperature excursion of 68 degrees Fahrenheit for 8 hours. Data logger was involved. There was previous excursions reported: 57 degrees Fahrenheit for 2 hours.
Vaginal spotting starting 2 weeks after 1st covid vaccine. Regular periods prior to vaccination. Spotting has persisted to the present. No regular period since the time of 1st covid vaccine.
A report has been received from a Health Professional concerning a 56 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that FLUMIST QUADRIVALENT inadvertently administered a person who was 56 on 20-Sep-2014. The outcome of the event of administered FLUMIST QUADRIVALENT to a 56 YO is unknown. The report was considered to be non-serious.
Patient presented to Covenant on 01/07 for loss of appetite for the past 3 days . Patient noted to have generalized myalgias.  Patient has chronic shortness of breath secondary to lung cancer. Patient noted to have this productive cough for the past 3 days which appeared to be bloody intermittently.  He never experiences before.  Patient denies any chest pain.  No fever, vomiting, diarrhea. \  Per patient, he states he lost 8-10 lbs in 3 days. Patient was admitted with Sepsis secondary to COVID-19 pneumonia with possible concomitant bacterial community-acquired pneumonia.  Patient on room air.  Patient was given IVF, Rocephin, azithromycin.    Azithromycin switched to doxycycline.   Remdesivir ordered. Patient developed back pain with monoclonal antibodies; hence it was stopped.  Back pain resolved after stopping monoclonal antibody.   On 01/09, WBC WNL.  HGB 9.3.  ALC stable.  Total bili WNL.  CRP/PCT improved.  2D echo:  LVEF 50-55%, mild MR.   Today, HGB improved to 10.5.  ALC improved. Negative Sputum culture. Negative HS troponin/EKG.  CRP/PCT improved.  Patient is being discharged on oral antibiotics.    Patient passed home O2 eval.  There was a concern for chest discomfort per CT chest:  No PE; it showed consolidation in the left lower lobe with diffuse emphysematous changes.   Patient is being discharged in stable condition.
After returning home from our office (received 4mg shots) hives and rash appeared on both lower extremities, inconsolable, non-stop crying for 2 hours.
Client received 1st Pfizer dose and approx. 7 minutes later c/o being "light-headed", having "tunnel vision" and was observed to be diaphoretic and pallor. He was led to a zero gravity chair by EMT and experienced syncope for several seconds. When he regained consciousness, V/S were taken every 5 mins, all WNL. At 9:50am, he reported feeling a little better but a light headed. At 10am, he was observed to have normal skin tone, no diaphoresis, and walked away unassisted  with a friend who came to pick him up. He reported "feeling better." Client reported to RN that he has a history of "passing out when giving blood." No medication was given.
This spontaneous report as received from a Registered Nurse refers to an unspecified number of patients of unknown age and gender. The patient's medical histories and concurrent conditions were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ oral, (lot numbers and expiration dates were not provided). No concomitant therapies were reported, neither was any adverse effect. This is one of several reports from the same reporter. Additional information has been requested.
Fever, chills, night sweats, full body muscle pain, nausea, headache, dizziness. Resolved after 48 hours, ibuprofen helped relieve symptoms.
Patient received vaccines and then got up to walk the store. After about 5 minutes the patient came back in a breathing distress and showing lower back pain. She stated she didn't fell right and was thinking she was having a reaction to the "new" Covid vaccine. I had the patient take a seat and attempted to have her describe what she was feeling. Her back was spasming and she had erratic breaking. At this time her daughter came along and attempted to comfort her. Patient was distressed for about 10 minutes and working on her breathing and some cold water eventually got her to a calm place. Informed her I would report the event to VAERS thereafter and both patient and daughter departed about 10minutes after.
Itchy rash on arms, trunk and upper legs.  Symptoms started one day (16 May 04).  No other symptoms reported.  Member denied, fever, dyspnea or any other S&S.  Denied any problems with first anthrax dose.  On exam several small bumps that looked similar to heat rash were on forearm.  Vaccination site slightly pink.  Member first noticed rash after running on 16 May.  Member worked in yard on same day as vaccine given, but was wearing long sleeve shirt.  No treatment given.  Member told if symptoms got worse or didn't resolve to see his PCP.  Symptoms resolved in 2 weeks.
Sore and pain on arm of injection, headache and faint feeling, nausea, red rash covering arm, fever.
Ventricular tachycardia 02/20/07-records received and reviewed for DOS 01/21-01/29/07; DC DX: ventricular tachycardia. Presented to clinic on 1/18/07 with poor feeding and rapid heart rate. Heart rate in ER 260 and 280 felt to be in stable SVT and received two doses of adenosine without any change. Fluid resuscitated and given amiodaron with resolution of tachycardia. Episodes of bigeminy, trigeminy and PVCs. Transported to another Hospital.  PMH:multiple ophthalmic abnormalities including bilateral microcornea, bilateral sclerocornea with opacification and bilateral micro-ophthalmus. Nonaccidental trauma left arm 11/06. PE:Oxygen sats on RA 98%. WNL
After a few minutes, patient fainted and fell to the floor. Patient was laying on the floor for about 10 seconds and started to move. He stayed on the floor a few more minutes and then stood up and moved to a chair.  Patient stayed in the chair for about 20 minutes and then left the pharmacy.
Warmth, redness, and swelling of upper arm well beyond the injection site, which is the deltoid muscle.  The reaction was noted approximately 32 hours after administration of the vaccine, but it is unknown when it first appeared, due to the affected patient wearing sleeves that covered the area.  No adverse reactions have occured with any previously administered vaccines.  No treatment at this time, but the reaction was reported to the healthcare provider that administered the vaccine.